Seelos Therapeutics Inc (SEEL): Whatever happened to using Nexact and al...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Seelos Therapeutics Inc (SEEL)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	2489
Boards Moderated	0
Alias Born	05/03/2012

Re: None

Monday, 11/04/2013 1:28:11 PM

Monday, November 04, 2013 1:28:11 PM

Whatever happened to using Nexact and alprodastil for Raynauds Syndrome?

That was about the time I was into my first year of ownership in this stock. I forgot, didn't they receive fast track or orphan drug status? This could have been huge and think about the application with diabetes. They could not find a partner willing to develop it? Or a grant from one of the many diabetes foundations? Anyone recall some of the other drugs they mentioned (not Prevonco)?

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SEEL News

Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM

More SEEL News

InvestorsHub NewsWire

FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow